Current Issue January 2012, Vol. 163, No. 1

Issue Highlights

Design of the Trial to Assess Chelation Therapy (TACT)
January 2012 (Vol. 163 | No. 1 | Pages 7-12)
Gervasio A. Lamas, Christine Goertz, Robin Boineau, Daniel B. Mark, Theodore Rozema, Richard L. Nahin, Jeanne A. Drisko, Kerry L. Lee
Eliminating untimely deaths of women from heart disease: Highlights from the Minnesota Women's Heart Summit
January 2012 (Vol. 163 | No. 1 | Pages 39-48.e1)
Ruth Lindquist, Jackie L. Boucher, Elizabeth Zane Grey, Beth Cairns, Shalini Bobra, Denise Windenburg, Suma Konety, Kevin Graham, Russell Luepker, Sharonne N. Hayes
A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder
January 2012 (Vol. 163 | No. 1 | Pages 27-32)
William B. White, Deborah Grady, Linda C. Giudice, Scott M. Berry, Joanne Zborowski, Michael C. Snabes

Low-dose dobutamine test associated with interventricular dyssynchrony: A useful tool to identify cardiac resynchronization therapy responders: Data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study
20 January 2012
Maurizio Gasparini, Carmine Muto, Saverio Iacopino, Francesco Zanon, Cosimo Dicandia, Giuseppe Distefano, Stefano Favale, Carlo Peraldo Neja, Renato Bragato, Mario Davinelli, Lorenza Mangoni, Alessandra Denaro
Background: Cardiac resynchronization therapy (CRT) is effective in patients with heart failure, but 30% to 50% of subjects are classified as nonresponders. Identifying responders remains a challengin...
High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: A pilot randomized controlled trial
16 January 2012
Anil M. Ranchord, Rachel Argyle, Rhys Beynon, Kyle Perrin, Vishal Sharma, Mark Weatherall, Mark Simmonds, Grant Heatlie, Nicholas Brooks, Richard Beasley
Background: The optimal approach to oxygen therapy in ST-elevation myocardial infarction (STEMI) is uncertain. Methods: A randomized controlled trial was undertaken in which 136 patients presenting wi...
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures
16 January 2012
Francesco Burzotta, Carlo Trani, Mario Attilio Mazzari, Antonella Tommasino, Giampaolo Niccoli, Italo Porto, Antonio Maria Leone, Giovanni Tinelli, Valentina Coluccia, Maria De Vita, Marta Brancati, Rocco Mongiardo, Giovanni Schiavoni, Filippo Crea
Background: Randomized trials have shown that transradial approach, compared with transfemoral, reduces vascular complications (VCs) of coronary procedures in selected patients. Yet, radial approach i...

View More Articles in Press...

Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials
July 2011 (Vol. 162 | No. 1 | Pages 115-124.e2)
Jeffrey S. Berger, Anuradha Lala, Mori J. Krantz, Gizelle S. Baker, William R. Hiatt
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
November 2010 (Vol. 160 | No. 5 | Pages 785-794.e10)
SHARP Collaborative Group
Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): Characteristics of a randomized trial among 12064 myocardial infarction survivors
November 2007 (Vol. 154 | No. 5 | Pages 815-823.e6)
SEARCH Study Collaborative Group
Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
May 2009 (Vol. 157 | No. 5 | Pages 805-810.e2)
Michael D. Ezekowitz, Stuart Connolly, Amit Parekh, Paul A. Reilly, Jeanne Varrone, Susan Wang, Jonas Oldgren, Ellison Themeles, Lars Wallentin, Salim Yusuf
The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH)
March 2011 (Vol. 161 | No. 3 | Pages 471-477.e2)
The AIM-HIGH Investigators

Most Read lists are compiled every quarter.

On the Cover

New Issue Alert

Free Trial Issue

About American Heart Journal

American Heart Journal has been a trusted resource for cardiologists and general practice physicians for more than 80 years. The Journal focuses its content to respond to the information needs of the cardiology community. In addition to publishing results of important clinical investigations, the Journal addresses such topics as cost-effectiveness, design of clinical trials, reports of negative clinical trials, and the changing organization of medical care.

Impact Factor

2010 Impact Factor* 5.052!
13 out of 114 journals listed
*Journal Citation Reports®, published by Thomson Reuters

Journal Access

Full-text articles and abstracts are available to personal subscribers starting from 1997 to the present; access to abstracts is complimentary. Click here for additional information.

Already have a username and password? Click here to log in.

First-time User? Create an account here.

Institutional subscribers: Click here to access your journal subscription.

Subscribe to the journal now!

American Heart Journal Video Library

Loading Video. Please wait...

The First Call from Dad

Video--flashvideo1ymhj--http://podcasts.elsevierhealth.com/ymhj/ymhj_162_5.flv--/webfiles/images/journals/ymhj/lisa.png

Transradial Angiography and Intervention Focus Issue: Call for Papers

In recognition of the increasing interest and adoption of transradial angiography and intervention, the American Heart Journal will publish a special section dedicated to transradial invasive procedures, in the September 2012 issue. Studies that will be considered for publication include observational analyses or randomized trials that examine technical issues, implementation, or outcomes. Manuscripts should be submitted by June 30, 2012.

To submit your manuscript and for Instructions to Authors, visit http://ees.elsevier.com/ahj/.

For further information, contact Guest Editor Sunil Rao, MD, at sunil.rao@dm.duke.edu.

Access this journal onSciVerse ScienceDirect

Publishing Information

American Heart Journal is published by Elsevier.